Voluntary Field Corrective Action issued for two (2) lots of Vial2Bag Advanced® 20mm Admixture Device

On September 24, 2024, West has issued a voluntary Field Safety Corrective Action, instructing our distributor and end-user facilities to discontinue use and return two (2) lots of Vial2Bag Advanced® 20mm Admixture Devices. Our top priority is the safety of all patients utilizing our products and meeting our commitment to quality.

Click here for the Consignee Letter for more information.

Last Updated on September 25,  2024

Israel - West Pharmaceutical Services, Inc. Update – June 2025

West is committed to providing timely and transparent communications to all our stakeholders regarding the ongoing events in Israel and their impact to our manufacturing operations at our West Israel facilities.

In response to the recent escalation and hostile activities in Israel and surrounding regions, our first priority remains the safety and welfare of our team members and their families. At this time, we can confirm that West and its suppliers and partners remain operational with no substantial disruption to our manufacturing and supply chain operations. Our primary logistics lanes remain open and functional.

We appreciate your understanding as this remains a dynamic situation and we will continue to keep you updated on any changes that impact your business operations.

Last Updated June 17, 2025